Approval · Notice of Compliance 21925 · 2019
ONCASPAR: Notice of Compliance 21925
Issued March 5, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21925
- Date
- March 5, 2019
- Company
- Servier Canada Inc.Laval, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product monograph update
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ONCASPAR | Not yet assigned | — |
Medicinal ingredients
- PEGASPARGASE 750 UNIT per ML